Scotland Drug Harm Reduction Workbench

Dynamic epidemiological simulation of illicit synthetic benzo/opioid flows & evidence-based harm reduction

Cohort: 10,000 High-Risk Individuals

Policy Presets:

Projected Fatalities

692

Baseline: 1,240 / yr

Net Lives Saved

+548

44.2% reduction

12-Mo Treatment Retention

64.5%

+32.5% vs Baseline

Ambulance Callout Relief

3,890

Diversions & Reversals

Intervention Levers

MAT Standard 1: Same-Day Prescribing

Eliminates clinical backlog; immediate buprenorphine/methadone

Safer Consumption Facilities (SCFs)

Supervised injection/inhalation with immediate oxygen & naloxone

Community Drug Checking & EWS

Identifies high-potency nitazenes and novel illicit street benzos

Peer Take-Home Naloxone Coverage 85%

Saturation among peers, family, and postal/first-responders

Residential Rehab & Detox Beds +40%

Long-term dual-diagnosis and trauma-informed inpatient beds

Cohort Epidemiological State Flow (10,000 Individuals) Real-time stochastic transition

Data modeled from Scottish Drug Deaths Taskforce & Public Health Scotland

Inspect Mathematical Model & Evidence Assumptions

Social Media Supply & Polydrug Hazards

Telegram/WhatsApp illicit distribution drives bulk 'street Valium' (etizolam/bromazolam) combined with opioids. Polydrug prevalence defaults to 78% with compounded respiratory depression factor (2.6x lethality).

MAT Standard 1 Efficacy

Same-day low-threshold opioid agonist therapy (OAT) reduces 12-month all-cause mortality hazard ratio by 0.53 and increases retention from 32% to 64.5%.

Safer Consumption Facilities (SCFs)

Overdose events within supervised spaces exhibit ~0% case fatality rate due to trained medical oxygenation and immediate peer naloxone titration.

Drug Checking Early-Warning

Point-of-care spectrometry alerts users to bromazolam/xylazine adulteration, reducing lethal unmonitored exposure by 22%.

Enjoy this tool? Build your own with Super